Along with his colleagues at the University of Florida, Atkinson is pursuing a vaccine strategy for preventing type 1 diabetes.
In addition to OneVax, Atkinson is a consultant to a number of companies in the pharmaceutical/biotechnology industry including Diamyd Medical, Genzyme, Sanofi, Novo Nordisk, GlaxoSmithKline, Merck, and others [REF].